EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access

Hydrocodone vs Oxycodone and Postoperative Pain and Opioid Use in Joint Arthroplasty

Noor A Nahid, Natasha J Petry, Jordan F Baye, Chancellor F Gray, Rachel A Myers, Erica N Elwood, Elizabeth C Harris, Hrishikesh Chakraborty, Simona Volpi, Renee Rider, Paul R Dexter, Josh F Peterson und 5 weitere

JAMA Network Open · 14.07.2026 · 9 (7) · e2623079

DOI: 10.1001/jamanetworkopen.2026.23079 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA Network Open, online erschienen am 14.07.2026. Verfasst von Noor A Nahid und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus. Hauptthemen laut MEDLINE: Hydrocodone, Oxycodone, Postoperative Pain, Analgesics, Opioid. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Oxycodone and hydrocodone are the most frequently prescribed opioids for postoperative joint arthroplasty pain, yet comparative effectiveness data remain limited.

Objective

To compare postoperative pain outcomes and opioid consumption for hydrocodone vs oxycodone among patients undergoing elective joint arthroplasty. Design, Setting, and Participants This cohort study was a preplanned secondary analysis of a randomized clinical trial conducted among cytochrome P450 2D6 (CYP2D6) normal metabolizers (NMs) who underwent elective joint arthroplasty in 5 US surgery clinical sites from March 2021 to September 2023 and received hydrocodone or oxycodone postoperatively. Follow-up concluded in March 2024. Data analysis was conducted from October 2024 to December 2025. Exposure Postoperative analgesia with hydrocodone or oxycodone within a multimodal pain management approach (opioids and nonopioids). Main Outcomes and Measures Coprimary outcomes were composite pain score at postoperative day 10 (sum of current, worst, and mean pain over 7 days; range 3-15) and cumulative morphine milligram equivalents (MMEs) over 10 days. Secondary outcomes included mobility scores at day 10 and Patient-Reported Outcomes Measurement Information System anxiety and depression scores at day 30. Multivariable regressions were adjusted for demographic and clinical covariates.

Results

Among 663 participants (mean [SD] age, 66 [10.6] years; 384 [57.9%] female), 217 received oxycodone and 446 received hydrocodone. Hydrocodone was associated with significantly lower composite pain scores compared with oxycodone (mean [SD], 9.0 [2.0] vs 9.3 [2.2]; adjusted P = .001) and significantly lower cumulative MME (mean [SD], 93.5 [159.3] vs 154.5 [121.6]; adjusted P < .001). Secondary outcomes did not differ between groups (mobility score: mean [SD], 26.3 [10.4] vs 30.9 [14.7]; P = .29; anxiety score: mean [SD], 45.4 [8.3] vs 45.5 [8.7]; P = .31; depression score: mean [SD], 43.8 [7.8] vs 44.0 [7.9]; P = .97). Findings were consistent in sensitivity analyses, restricting to opioid and acetaminophen combinations, restricting to sites prescribing both opioids, and in subgroups of knee arthroplasty, but not consistent in hip arthroplasty. Conclusions and Relevance In this cohort study of CYP2D6 NMs undergoing joint arthroplasty, within multimodal analgesia, hydrocodone provided comparable pain control to oxycodone with significantly lower opioid exposure, supporting its use as a viable and possibly preferable analgesic option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrocodoneOxycodonePostoperative PainAnalgesics, OpioidHumansFemaleMaleAgedMiddle AgedPain MeasurementCohort StudiesPain Management

Substanzen

HydrocodoneOxycodoneAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus.
  • Department of Pharmacy Practice, School of Pharmacy, North Dakota State University, Fargo.
  • Sanford Health Imagenetics, Sioux Falls, South Dakota.
  • Department of Pharmacy Practice, South Dakota State University, Brookings.
  • Florida Orthopaedic Institute, Gainesville.
  • Clinical Research Unit, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Zitieren

APA

Nahid, N. A., Petry, N. J., Baye, J. F., Gray, C. F., Myers, R. A., Elwood, E. N., Harris, E. C., Chakraborty, H., Volpi, S., Rider, R., Dexter, P. R., Peterson, J. F., Skaar, T. C., Parvataneni, H. K., Cavallari, L. H., Johnson, J. A., & IGNITE Investigators (2026). Hydrocodone vs Oxycodone and Postoperative Pain and Opioid Use in Joint Arthroplasty. JAMA Network Open, 9(7), e2623079. https://doi.org/10.1001/jamanetworkopen.2026.23079

Vancouver

Nahid NA, Petry NJ, Baye JF, Gray CF, Myers RA, Elwood EN, et al. Hydrocodone vs Oxycodone and Postoperative Pain and Opioid Use in Joint Arthroplasty. JAMA Network Open. 2026;9(7):e2623079. doi:10.1001/jamanetworkopen.2026.23079

BibTeX
@article{Nahid2026,
  author = {Nahid, Noor A and Petry, Natasha J and Baye, Jordan F and Gray, Chancellor F and Myers, Rachel A and Elwood, Erica N and Harris, Elizabeth C and Chakraborty, Hrishikesh and Volpi, Simona and Rider, Renee and Dexter, Paul R and Peterson, Josh F and Skaar, Todd C and Parvataneni, Hari K and Cavallari, Larisa H and Johnson, Julie A and IGNITE Investigators, IGNITE Investigators},
  title = {Hydrocodone vs Oxycodone and Postoperative Pain and Opioid Use in Joint Arthroplasty},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {e2623079},
  doi = {10.1001/jamanetworkopen.2026.23079}
}
Kostenlos starten →